Metformin and SGLT2 inhibitor combo may increase survival in diabetes patients with cirrhosis Medha Baranwal29 Dec 2023 2:00 AM ISTUSA: Dual treatment with metformin and SGLT2 inhibitor reduced hepatic complications and improved survival in type 2 diabetes (T2D) patients with...
Synokem Pharmaceutical Gets CDSCO Panel Nod To study Antidiabetic FDC Drug Dr. Divya Colin21 Dec 2023 6:00 PM ISTNew Delhi: With the condition of including more government sites distributed geographically, Synokem Pharmaceutical has got approval from the Subject...
Evergreen Talk Series: Linagliptin and Dapagliflozin combination for T2DM with Cardiovascular risk or established ASCVD MD Brand Connect21 Dec 2023 11:45 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr. Sameer I. Dani,...
Initiation of noninsulin second-line Antidiabetics fraught with risk of discontinuation within one year: Study Dr. Kamal Kant Kohli18 Dec 2023 12:30 AM ISTUSA: Adherence to second-line diabetes drugs can be hit or miss among patients with type 2 diabetes, a recent study has reported.The findings...
Modify phase III clinical trial protocol: CDSCO panel tells Akum Pharma on antidiabetic FDCÂ Dr. Divya Colin17 Dec 2023 5:30 PM ISTNew Delhi: Approving to conduct the bioequivalence (BE) study of the antidiabetic drug combination Repaglinide plus Voglibose plus Metformin...
Add on Metformin to insulin in pregnant women with diabetes fails to reduce neonatal complications: JAMA Medha Baranwal15 Dec 2023 10:15 AM ISTUSA: Metformin plus insulin treatment for preexisting type 2 or gestational diabetes diagnosed early in pregnancy failed to reduce a composite...
Conduct Phase III CT: CDSCO Panel Tells Akum Pharmaceutical on Antidiabetic FDC Dr. Divya Colin10 Dec 2023 6:00 PM ISTNew Delhi: Rejecting the proposal for the clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Metformin may act as protective shield against Acute Macular Degeneration in Diabetics Dr.Niharika Harsha B4 Dec 2023 7:00 PM ISTIn a groundbreaking study, researchers have uncovered a potential link between the use of the widely prescribed diabetes medication, metformin, and a...
First Indian Evidence: Triple FDC (DAPA, SITA, MET ER) Yields Better HbA1c Reduction in T2DM Patients Uncontrolled on Existing Therapy Dr. Kamal Kant Kohli2 Dec 2023 11:43 AM ISTAn approach of using a once-daily triple fixed-dose combination of dapagliflozin, sitagliptin, and metformin ER (extended-release) in Indian type 2...
Evergreen Talk Series: Clinical applicability of Linagliptin in T2DM across CKD spectrum and Dapagliflozin up to CKD stage 4 MD Brand Connect1 Dec 2023 11:17 AM IST Advertisement Presenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and...
Early introduction of metformin yields maternal and neonatal health benefits in women with gestational diabetes Medha Baranwal23 Nov 2023 9:45 AM ISTIreland: The early introduction of metformin in women with gestational diabetes mellitus (GDM) is associated with significant maternal and neonatal...
Diabetes drug for prostate cancer? Columbia study provides clarity Dr. Kamal Kant Kohli16 Nov 2023 8:00 PM ISTIn the years since a 2005 study found that diabetes patients taking metformin had lower rates of cancer, oncologists have been excited by the prospect...
